Medrobotics Corp. is expanding into general surgical, gynecological and thoracic procedures with its latest FDA-cleared indication. The Raynham, Mass.-based company's Flex Robotic system previously had indications for oropharynx, hypopharynx and larynx procedures. The company is also pursuing expansion of applications to other areas including transvaginal gynecologic procedures. Read More
